Stress worsens skin woes for students
A study of university students has shown that certain skin problems, including alopecia and pruritis can be exacerbated by stress.
Monthly Archives: November 2015
Prices rise for prescription dermatologic drugs
A study shows that prices of prescription dermatologic drugs have risen dramatically in the US, becoming less affordable as insurance companies increasingly restrict formularies.
New finding offers hope for diabetic wound healing
University of Notre Dame researchers have discovered a compound that accelerates diabetic wound healing, which may open the door to new treatment strategies.
Combination of pills for advanced skin cancer extends survival compared with previous monotherapy
The combination of cobimetinib and Zelboraf® (vemurafenib) has been shown to extend the lives of previously untreated patients with advanced skin cancer to nearly two years (22.
Stretch mark science: What happens to your skin when pregnancy gives you a stretch mark?
Most topical treatments currently available are not evidence-based.Don't believe the hype when you see those creams and ointments promising to prevent or reduce pregnancy stretch marks.
Firefighter undergoes world’s most extensive face transplant
Doctors have completed the most extensive face transplant to date, giving a 41-year-old man injured as a firefighter in 2001 a new face from a 26-year-old donor.
New guideline for treating acne in children and adults
A new guideline aims to help Canadian physicians, nurses and pharmacists treat children and adults with acne, a disease that can severely affect quality of life.
Color changing Band-Aid gives early warning of infection
A groundbreaking wound dressing for burns that changes color in response to infection could help in the fight against global antibiotic resistance.
Drug combination for advanced melanoma wins FDA approval
US regulators have approved a drug combination - vemurafenib (Zelboraf) and cobimetinib (Cotellic) - for advanced melanoma that shows great promise in extending patients' lives.
Melanoma’s genetic trajectories are charted in new study
Study confirms 'intermediate' disease stage between benign moles and malignancy.